2026– date –
-
Smart Nanoplatforms Revolutionize Precision Cancer Therapy: Enhancing Drug Delivery and Immune Modulation
Bioengineer.org USA Overview A special issue of *Cancer Biology & Medicine* highlights nanotechnology's transformative role in precision cancer therapy, projecting a future where nanomedicine enhances existing treatments and unlocks ... -
Novel Cobalt Phosphide Heterojunction Catalyst Achieves Record-Low Overpotentials for Green Hydrogen Production
EurekAlert! China Overview Fuzhou University researchers synthesized a novel bifunctional electrocatalyst, cobalt phosphide (CoP/Co2P) heterojunctions on N,P-doped hollow carbon nanorods, delivering highly efficient and stable green hydr... -
ALD Breakthroughs Propel 2nm Logic and AI Hardware: Molybdenum Contacts and Ferroelectric TiO2 Unveiled
Atomic Layer Deposition USA Overview Atomic Layer Deposition (ALD) is entering a "supercycle" driven by 2nm logic and AI hardware demand, with Applied Materials introducing a Spectral™ ALD system that reduces transistor contact resistanc... -
Nanomedicine Shifts to Industrial-Scale Production in 2026, Driven by Quality by Design and AI
NanoApps Medical Netherlands Overview Experts predict 2026 as the pivotal year for nanomedicine's transition from proof-of-concept to reliable industrial-scale production. This shift emphasizes "Quality by Design" principles, integrating... -
Evolving Nanomaterial Regulations Drive Innovation and Growth in Chemical Industry
Frost & Sullivan USA Overview Regulatory frameworks for advanced nanomaterials, including carbon nanotubes and MOFs, are rapidly evolving across Europe, North America, and Asia-Pacific, compelling the chemical industry to accelerate inve... -
XellSmart Initiates Phase II Trial for iPSC-Based Parkinson’s Therapy Following Encouraging Phase I Results
The Regen Report USA Overview XellSmart has advanced its iPSC-derived cellular therapy for Parkinson's disease into Phase II clinical trials, driven by positive safety and preliminary efficacy data from its Phase I study. This critical p... -
NIH-Funded Research Achieves Breakthrough in Shrinking CRISPR Systems for Enhanced In Vivo Precision Delivery
European AIDS Treatment Group (EATG) News USA Overview NIH-funded research has successfully developed miniaturized CRISPR-Cas gene editing systems, overcoming a significant hurdle in in vivo delivery for traditional larger systems. This ... -
Cell-Easy Launches Large-Scale iPSC-Derived Beta Cell Program to Address Manufacturing Bottlenecks for Diabetes Therapy
BioInformant USA Overview Cell-Easy has initiated a new program focused on scaling up the manufacturing of iPSC-derived beta cells, addressing a critical bottleneck for diabetes therapies. This initiative aims to establish a stable, high... -
Americord Registry Spotlights Latest Breakthroughs in iPSC Clinical Trials Across Diverse Disease Areas
Americord Registry USA Overview Americord Registry has released a comprehensive report detailing the latest advancements in iPSC clinical trials, highlighting expanding applications in neurological and ophthalmic conditions. The report i... -
Locus Cell Establishes Large-Scale Manufacturing Process for Human Umbilical Cord Mesenchymal Stem Cells Using CellFiber® Technology
PR Times Japan Overview Locus Cell Inc., in collaboration with CellFiber Inc., has announced the successful establishment of a large-scale, high-efficiency manufacturing process for human umbilical cord-derived mesenchymal stem cells (UC...
